全文获取类型
收费全文 | 5185篇 |
免费 | 261篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 82篇 |
妇产科学 | 63篇 |
基础医学 | 649篇 |
口腔科学 | 80篇 |
临床医学 | 302篇 |
内科学 | 1504篇 |
皮肤病学 | 43篇 |
神经病学 | 429篇 |
特种医学 | 194篇 |
外科学 | 938篇 |
综合类 | 37篇 |
预防医学 | 146篇 |
眼科学 | 138篇 |
药学 | 335篇 |
中国医学 | 9篇 |
肿瘤学 | 490篇 |
出版年
2023年 | 22篇 |
2022年 | 37篇 |
2021年 | 88篇 |
2020年 | 41篇 |
2019年 | 63篇 |
2018年 | 85篇 |
2017年 | 74篇 |
2016年 | 73篇 |
2015年 | 88篇 |
2014年 | 121篇 |
2013年 | 150篇 |
2012年 | 276篇 |
2011年 | 299篇 |
2010年 | 168篇 |
2009年 | 166篇 |
2008年 | 265篇 |
2007年 | 305篇 |
2006年 | 288篇 |
2005年 | 314篇 |
2004年 | 307篇 |
2003年 | 281篇 |
2002年 | 289篇 |
2001年 | 147篇 |
2000年 | 138篇 |
1999年 | 143篇 |
1998年 | 73篇 |
1997年 | 48篇 |
1996年 | 48篇 |
1995年 | 45篇 |
1994年 | 49篇 |
1993年 | 41篇 |
1992年 | 101篇 |
1991年 | 73篇 |
1990年 | 75篇 |
1989年 | 93篇 |
1988年 | 83篇 |
1987年 | 65篇 |
1986年 | 51篇 |
1985年 | 56篇 |
1984年 | 41篇 |
1983年 | 42篇 |
1982年 | 21篇 |
1981年 | 17篇 |
1980年 | 23篇 |
1979年 | 24篇 |
1977年 | 19篇 |
1976年 | 16篇 |
1973年 | 17篇 |
1969年 | 18篇 |
1966年 | 15篇 |
排序方式: 共有5483条查询结果,搜索用时 15 毫秒
171.
172.
Tomokazu Kawaoka Shoichi Takahashi Yumiko Tatsukawa Akira Hiramatsu Nobuhiko Hiraga Daiki Miki Masataka Tsuge Michio Imamura Yoshiiku Kawakami Hiroshi Aikata Hidenori Ochi Kouhei Ishiyama Kentaro Ide Hirotaka Tashiro Hideki Ohdan Kazuaki Chayama 《Hepatology research》2014,44(12):1259-1264
It is difficult to use protease inhibitors in patients with recurrent hepatitis C virus (HCV) infection after liver transplantation (LT) due to interaction with immunosuppressive drugs. We report our experience with two patients treated with telaprevir (TVR) combined with pegylated interferon/ribavirin (PEG IFN/RBV) for recurrent HCV genotype 1 infection after LT. The first was a 63‐year‐old man with HCV‐related liver cirrhosis, who failed to respond to IFN‐β plus RBV after LT. Treatment was switched to PEG IFN‐α‐2b plus RBV and TVR was started. The donor had TT genotype of interleukin (IL)‐28 single nucleotide polymorphisms (SNP) (rs8099917). The recipient had TT genotype of IL‐28 SNP (rs8099917). Completion of 12‐week triple therapy was followed by PEG IFN‐α‐2b plus RBV for 36 weeks. Finally, he had sustained viral response. The second was a 70‐year‐old woman with HCV‐related liver cirrhosis and hepatocellular carcinoma. She failed to respond to PEG IFN‐α‐2b plus RBV after LT, and was subsequently switched to PEG IFN‐α‐2b/RBV/TVR. Genotype analysis showed TG genotype of IL‐28 SNP for the donor, and TT genotype of IL‐28 SNP for the recipient. Serum HCV RNA titer decreased below the detection limit at 5 weeks. However, triple therapy was withdrawn at 11 weeks due to general fatigue, which resulted in HCV RNA rebound 4 weeks later. Both patients were treated with cyclosporin, starting with a small dose to avoid interactions with TVR. TVR is a potentially suitable agent for LT recipients who do not respond to PEG IFN‐α‐2b plus RBV after LT. 相似文献
173.
174.
175.
Rat subthalamic nucleus and zona incerta share extensively overlapped representations of cortical functional territories 下载免费PDF全文
The subthalamic nucleus (STN) and the zona incerta (ZI) are two major structures of the subthalamus. The STN has strong connections between the basal ganglia and related nuclei. The ZI has strong connections between brainstem reticular nuclei, sensory nuclei, and nonspecific thalamic nuclei. Both the STN and ZI receive heavy projections from a subgroup of layer V neurons in the cerebral cortex. The major goal of this study was to investigate the following two questions about the cortico‐subthalamic projections using the lentivirus anterograde tracing method in the rat: 1) whether cortical projections to the STN and ZI have independent functional organizations or a global organization encompassing the entire subthalamus as a whole; and 2) how the cortical functional zones are represented in the subthalamus. This study revealed that the subthalamus receives heavy projections from the motor and sensory cortices, that the cortico‐subthalamic projections have a large‐scale functional organization that encompasses both the STN and two subdivisions of the ZI, and that the group of cortical axons that originate from a particular area of the cortex sequentially innervate and form separate terminal fields in the STN and ZI. The terminal zones formed by different cortical functional areas have highly overlapped and fuzzy borders, as do the somatotopic representations of the sensorimotor cortex in the subthalamus. The present study suggests that the layer V neurons in the wide areas of the sensorimotor cortex simultaneously control STN and ZI neurons. Together with other known afferent and efferent connections, possible new functionality of the STN and ZI is discussed. J. Comp. Neurol. 522:4043–4056, 2014. © 2014 Wiley Periodicals, Inc. 相似文献
176.
177.
178.
Saito T Muro T Takeda H Hyodo E Ehara S Nakamura Y Hanatani A Shimada K Yoshiyama M 《The American journal of cardiology》2012,110(1):93-97
Recently, an aortic valve area (AVA) index (AVAI) <0.6 cm(2)/m(2) was proposed as an indicator of severe aortic stenosis. The purpose of the present study was to clarify the prognostic value of the AVAI. We identified 103 consecutive asymptomatic patients (mean age 72 ± 11 years) with severe aortic stenosis, defined by an AVA of <1.0 cm(2), who had not undergone aortic valve replacement on initial evaluation. During follow-up (median 36 ± 27 months), 31 aortic valve replacements and 20 cardiac deaths occurred. Multivariate analysis revealed that an AVAI <0.6 cm(2)/m(2) (hazard ratio 2.6, 95% confidence interval 1.1 to 6.3; p = 0.03) and peak aortic jet velocity (Vp) >4.0 m/s (hazard ratio 2.6, 95% confidence interval 1.2 to 5.8; p = 0.02) were associated with cardiac events but that an AVA <0.75 cm(2) was not. The event-free survival of patients with an AVAI of ≥0.6 cm(2)/m(2) was better than that for those with an AVAI <0.6 cm(2)/m(2) (86% vs 41% at 3 years, p <0.01). Furthermore, patients with an AVAI of ≥0.6 cm(2)/m(2) and Vp of ≤4.0 m/s showed an excellent prognosis, but those without these findings had poorer outcomes. In conclusion, AVAI is a powerful predictor of adverse events in asymptomatic patients with severe aortic stenosis. Furthermore, the combination of AVAI and Vp provides additional prognostic information. Watchful observations are required for timely aortic valve replacement in patients with an AVAI of <0.6 cm(2)/m(2) or a Vp >4.0 m/s. 相似文献
179.
Natsuaki M Nakagawa Y Morimoto T Ono K Shizuta S Furukawa Y Kadota K Iwabuchi M Kato Y Suwa S Inada T Doi O Takizawa A Nobuyoshi M Kita T Kimura T;CREDO-Kyoto PCI/CABG Registry Cohort- Investigators 《The American journal of cardiology》2012,109(10):1387-1396
Therapeutic strategies preventing late target lesion revascularization (TLR) after drug-eluting stent implantation have not been yet adequately investigated. In 13,087 consecutive patients undergoing first percutaneous coronary intervention in the CREDO-Kyoto Registry Cohort-2, we identified 10,221 patients who were discharged alive after implantation of sirolimus-eluting stents (SESs) only (SES stratum 5,029) or bare-metal stents (BMSs) only (BMS stratum 5,192). Impact of statin therapy at time of discharge from the index hospitalization on early (within the first year) and late (1 year to 4 years) TLR, was assessed in the SES stratum (statin group 2,735; nonstatin group 2,294) and in the BMS stratum (statin group 2,576; nonstatin group 2,616). Despite a significantly lower incidence of early TLR (7.8% vs 22.2%, p <0.0001), SES use compared to BMS use was associated with a significantly higher incidence of late TLR (7.7% vs 3.0%, p <0.0001). In the SES and BMS strata, the incidence of early TLR was similar regardless of statin use. In the SES stratum, the incidence of late TLR was significantly lower in the statin group than in the nonstatin group (6.1% vs 9.6%, p = 0.002), whereas no significant difference was found in the BMS stratum (2.6% vs 3.3%, p = 0.38). After adjusting confounders, risk for late TLR significantly favored statin use in the SES stratum (hazard ratio 0.73, 95% confidence interval 0.54 to 0.98, p = 0.04), whereas the risk decrease was not significant in the BMS stratum (hazard ratio 0.74, 95% confidence interval 0.46 to 1.20, p = 0.23). In conclusion, statin therapy at hospital discharge was associated with a significantly lower risk for late TLR after SES implantation. 相似文献
180.
Jönsson F Mancardi DA Zhao W Kita Y Iannascoli B Khun H van Rooijen N Shimizu T Schwartz LB Daëron M Bruhns P 《Blood》2012,119(11):2533-2544
IgE and IgE receptors (FcεRI) are well-known inducers of allergy. We recently found in mice that active systemic anaphylaxis depends on IgG and IgG receptors (FcγRIIIA and FcγRIV) expressed by neutrophils, rather than on IgE and FcεRI expressed by mast cells and basophils. In humans, neutrophils, mast cells, basophils, and eosinophils do not express FcγRIIIA or FcγRIV, but FcγRIIA. We therefore investigated the possible role of FcγRIIA in allergy by generating novel FcγRIIA-transgenic mice, in which various models of allergic reactions induced by IgG could be studied. In mice, FcγRIIA was sufficient to trigger active and passive anaphylaxis, and airway inflammation in vivo. Blocking FcγRIIA in vivo abolished these reactions. We identified mast cells to be responsible for FcγRIIA-dependent passive cutaneous anaphylaxis, and monocytes/macrophages and neutrophils to be responsible for FcγRIIA-dependent passive systemic anaphylaxis. Supporting these findings, human mast cells, monocytes and neutrophils produced anaphylactogenic mediators after FcγRIIA engagement. IgG and FcγRIIA may therefore contribute to allergic and anaphylactic reactions in humans. 相似文献